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Objectives. Irritable bowel syndrome (IBS) is common and adversely affects patients’
quality of life. Multiple potential treatment options exist for patients (and clinicians) to
choose from,with limited evidence to inform treatment selection. The aimwas to explore
howpatientswith IBS go about seeking and appraising different treatmentmodalities, with
a view to elucidating the psychological processes involved and identifying opportunities to
improve clinical practice.
Design. Qualitative study nested within a randomized controlled trial of therapist-
delivered andweb-based cognitive behavioural therapy versus treatment-as-usual for IBS.
Methods. A total of 52 people participated in semi-structured interviews about their prior
experiencesof treatments for IBS.Transcriptswere analysedusing inductive thematic analysis.
Results. Key themes (desperation for a cure, disappointment at lack of cure, appraising
the effects of diverse treatments, and hope for positive effects) clustered around an
overarching theme of being trapped within a vicious cycle of hope and despair on
treatment seeking. A desperation andwillingness drove interviewees to try any treatment
modality available that might potentially offer relief. Coming to accept there is no cure for
IBS helped interviewees escape the vicious cycle. Treatments were appraised for their
effects on symptoms and quality of life while also considering, but rarely prioritizing, other
aspects including convenience of the regimen itself, whether it addressed the perceived
root causes of IBS, perceived side-effects, and cost.
Conclusion. Treatment seeking in IBS can be challenging for patients. Supportive
discussions with health care professionals about illness perceptions, treatment beliefs,
and goals could improve patients’ experiences.
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What is already known on this subject?
 Irritable bowel syndrome (IBS) is a highly prevalent chronic relapsing functional gastrointestinal
disorder.
 Studies show few treatment modalities provide complete symptom relief.
 IBS is associated with emotional and physical distress, and negatively impacts personal, social, and
professional aspects of quality of life.
What does this study add?
 Patients appraise IBS treatments for impact on quality of life and treatment characteristics.
 Developing acceptance and coping strategies helps escape treatment-seeking vicious cycles of hope
and despair.
 Clinicians could better support patients by discussing their illness perceptions, treatment goals, and
values.
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder or
disorder of gut-brain interaction, currently conceptualized as involving multiple
interacting biopsychosocial factors (Drossman, 2016). It affects around 10–14.9% of
the UK population with similar worldwide prevalence (for a review see Lovell &
Ford, 2012; Michalsen, Vandvik, & Farup, 2015), and it affects more women than
men (Quigley, Bytzer, Jones, & Mearin, 2006). Symptoms include abdominal pain,
discomfort, and altered bowel movements, and personal, social, professional, and
health-related quality of life is typically reduced (El-Serag, Olden, & Bjorkman,
2002; Hakanson, Sahlberg-Blom, Nyhlin, & Ternestedt, 2009; Taft, Keefer, Artz,
Bratten, & Jones, 2011; Taft, Ballou, & Keefer, 2013; Taft, Riehl, Dowjotas, & Keefer,
2014).
Few current treatments offer satisfactory symptom relief (Schoenfeld, 2005). NICE
clinical guidelines (2008, updated 2017) recommend clinicians provide advice on the
importance of self-help for the effective management of IBS, where self-help
encompasses lifestyle adjustments, general diet advice, advice to be physically active,
and symptom-focused medications. If general dietary advice is ineffective, then NICE
recommend single food avoidance and exclusion diets under the supervision of a
health care professional with expertise in dietary management. Beyond self-care, NICE
recommend considering pharmacological management based on symptom type and
severity, and the use of psychological therapies where symptoms have persisted for
more than 12 months.
Trials, systematic reviews, and meta-analyses suggest that some treatment modalities
are helpful in reducing IBS symptom severity. However, many trials lack methodological
rigour, thus the findings should be treatedwith caution. For instance, a limited number of
studies have tested the effectiveness of the low FermentableOligo-, Di-, Mono-saccharides
and Polypols (FODMAP) diet.While these studies report a reduction in symptom severity,
the effects are similar to other interventions, for example less-restrictive dietary advice
(see Eswaran, Chey, Han-Markey, Ball, & Jackson, 2016; Marsh, Eslick, & Eslick, 2016). In
relation to pharmacological interventions, a Cochrane review offered some support for
antidepressants, but little support for bulking agents and antispasmodics (Ruepert et al.,
2011). In relation to psychological interventions, systematic reviews and meta-analyses
have shown CBT to be efficacious in the short-term, with equivocal findings so far for
longer-term outcomes (Li, Xiong, Zhang, Yu, & Chen, 2014; Zijdenbos, de Wit, van der
Heijden, Rubin, & Quartero, 2009).
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The NICE guidelines recommend clinicians not to encourage the use of acupuncture
and reflexology, but between 20 and 50% of people with IBS use some form of
complementary or alternative medicine (CAM) (Carmona-Sanchez & Tostado-Fernandez,
2004; Hung, Kang, Bollom,Wolf, & Lembo, 2015; Koloski, Talley, Huskic, & Boyce, 2003;
Kong et al., 2005). Using CAM can be motivated by a lack of response to conventional
treatments and the disabling nature of IBS symptomology (Hussain & Quigley, 2006; Wu,
2010). While recent evidence suggests some CAMs may be helpful (see for example
Bensoussan et al., 2015; Cappello, Spezzaferro, Grossi, Manzoli, & Marzio, 2007;
Manheimer et al., 2012), Wu’s (2010) review found the poor quality of trials in this
area precluded judgements as to their effectiveness.
Hakanson et al. (2009) and Jakobson Ung, Ringstrom, Sj€ovall, and Simren (2013)
have explored how individuals seek ways of coping with, and adjusting to, life with
IBS. In these qualitative studies, interviewees were described as having an altered
self-image due to symptoms like bloating and flatulence (Hakanson et al., 2009),
wanting more autonomy in treatment decisions (Hakanson et al., 2009), coming to
accept they could not be cured (Jakobson Ung et al., 2013), and seeking coping
strategies to regain a sense of control in their lives (Hakanson et al., 2009; Jakobson
Ung et al., 2013). They also described living a life revolving round ‘periods of well-
being interspersed with periods of deterioration and illness’ (Jakobson Ung et al.,
2013, p. 1482). Relatedly, Paterson’s (2001) meta-synthesis described how living with
IBS involves diametrically opposite sequences, in which individuals mainly focused on
managing symptoms during flare-ups but on strategies to protect themselves from
further relapses in symptom-free times.
The idea that symptom experiences shape coping strategies has been formalized in
the Common Sense Model (Diefenbach & Leventhal, 1996; Leventhal, Meyer, & Nerez,
1980; Leventhal, Nerenz, & Steele, 1984). According to this model, when people
experience symptoms, they develop cognitive and affective representations that drive
coping strategies including treatment seeking. The experience and effects of treatment
are then appraised and inform modifications to illness representations, treatment
utilization, or both (Diefenbach & Leventhal, 1996; Horne, 2003; Horne & Weinman,
2002; Leventhal et al., 1980, 1984). The criteria by which patients appraise treatments
may vary by treatment and/or condition (Dima et al., 2013); for example, the therapist
might be particularly important in shaping appraisals of complementary therapies
(Bishop, Yardley, Cooper, Little, & Lewith, 2017; Yardley, Sharples, Beech, & Lewith,
2001) while beliefs about necessity and concerns are important for medications
(Horne et al., 2013).
The Common Sense Model has been applied in IBS, but the focus thus far has
been on the role of illness perceptions rather than treatment appraisals. De Gucht
(2015) found the impact of increased symptom severity on reduced health-related
quality of life was partially mediated by the illness perception dimensions of identity,
consequences, and emotional representation. Rutter and Rutter (2002) found higher
rates of anxiety and depression were strongly associated with perceiving IBS as having
severe consequences. Riedl et al. (2009) found that people who attributed their IBS
to psychological factors had a better quality of life than those with somatic
attributions. While qualitative studies have explored patients’ experiences of IBS in
general, no in-depth studies have explicitly focused on how patients experience and
appraise treatments. It is important to explore how patients experience and appraise
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treatments for IBS because of the treatment context faced by patients: A variety of
potential modalities which offer limited symptom relief that are not all widely
available on the NHS.
This study reports the findings from a qualitative study nested within a three-armed
randomized controlled trial of therapist- and web-based CBT vs treatment-as-usual for IBS
(the Assessing Cognitive Behavioural Therapy in Irritable Bowel trial, ACTIB; Everitt et al.,
2015). The aim was to explore how patients with refractory IBS seek and appraise
different treatment modalities tried prior to entering the trial. Patients’ experiences of
CBT in the trial will be reported elsewhere.
Method
Design
This qualitative study was nested within a large trial (summarized below) and used a
critical realist theoretical framework (Bhaskar, 1975; Gerrits & Verweij, 2015). Semi-
structured interviewswere conducted with a subsample of participants drawn from each
arm of the trial on completing trial treatments (3 months post-baseline). Adopting an
inductive and thematic approach permitted us to compare themes across individuals and
groups of people (e.g., genders, IBS severity scores, primary and secondary care) aswell as
analysing key themes across the whole data set.
The parent trial
Themain trial randomized patients to receive therapist-delivered CBT, web-based CBT, or
treatment-as-usual (see Table 1 for summary, and (Everitt et al., 2015) for full description
of interventions). Eligible patients were diagnosed with refractory IBS fulfilling the Rome
III criteria (Drossman, 2006) and were aged 18 years or over (for full details of trial
methods see (Everitt et al., 2015)).
Table 1. Summary of the interventions received by each trial arm

















Everitt et al., 2013)
Intensity Six, 60-min telephone CBT








Two 1-hr booster calls at
4- and 8-months
Two 30-min booster calls
at 4 and 8 months
Upon completion of the
trial, participants offered
the trial CBT intervention
Note. GPs and consultants were given a leaflet summarizing the NICE guidelines for IBS.
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Participants
Maximum variation sampling was employed to interview people with a diverse range of
characteristics: age, gender, ethnicity, geographical location, study arm, symptom
severity scores, and from primary and secondary care.
Fifty-two interviewswere conducted, 42 byAS and 10 by JMH. Intervieweeswere aged
from 21 to 74 years (M = 40.67, SD = 14.05) and had IBS for an average of 16.26 years
(SD = 9.96). Table 2 summarizes interviewees’ characteristics.






Primary care 10 19.23
Secondary care 25 48.07
Recruitment Site: Southampton
Primary care 15 28.85



















White British 38 73.08
White Other 9 17.31





Note. IBS SSS = IBS symptom severity score.
Treatment seeking and appraisal in IBS 565
Interviews
Semi-structured interviews used a topic guide comprising broad, open-ended questions
clustered into three sections: experiences of the trial to date, treatment regimens for IBS,
and daily experiences of emotions (findings from the latter have been published
separately; see (Sibelli et al., 2017)). This study focuses on interviewee responses to
questions exploring past treatment regimens for IBS. Questions included ‘could you tell
me about themost helpful/least helpful treatments you have tried for your IBS?’ and ‘What
did you like/dislike about these treatments?’ These questions did not explore the
interviewees’ experiences of CBT or treatment-as-usual received during the trial.
Interviews lasted on average 56 min (range 23–116) and were conducted face-to-face
(n = 10) or over the telephone (n = 42), as per participant request.
Procedure
Prior to commencing the study, favourable NHS ethical clearance was received (ref:
Berkshire REC 13/SC/0206). At the start of the trial, informed consent for interview
participation was obtained. Before commencing each interview, interviewers built
rapport, reminded interviewees of their rights, and obtained verbal consent. Interviews
were digitally recorded, then transcribed and coded using NVivo (version 10; QSR
International Ltd., 2012). Interviewers made field notes (e.g., observations of non-verbal
aspects) to inform later analysis and document their own reflections. All participant
names have been anonymized using pseudonyms to protect confidentiality.
Data analysis
Thematic analysis was used to identify themes (Joffe & Yardley, 2004) and followed the
procedure espoused by Braun and Clarke (2013). To achieve familiarizationwith the data,
interviews were listened to and transcripts read repeatedly. Memos were written to
capture the researcher’s subjective thoughts and feelings, and preserve ideas that may
become significant later in the analysis (Polit & Beck, 2004; Speziale & Carpenter, 2007).
To generate initial themes based on the data, JMH read each transcript and attached newly
devised labels to phrases and small chunks of data that addressed the research question.
After conducting open-coding in this way on five transcripts, all labels and associated data
excerpts were collated and reviewed. This process identified a large number of codes
which were used to code the remaining transcripts, adding more codes when new ideas
were encountered in the data.
Codes were defined in a coding manual and clustered around common themes;
clusters were identified by comparing different codes and associated data excerpts.
Preliminary themes were defined, diagrammed (in thematic maps), and reviewed against
transcripts to ensure coherence and consistency with the data set overall. Other
researchers were involved at this stage (FB, AS) to discuss the themes and suggest
alternative interpretations of the data, thus ensuring the analysis was neither idiosyncratic
nor inappropriately selective. Themes were modified and discussed iteratively and
finalized when the team agreed they captured the interviewees’ experiences of previous
IBS treatments.
We ran queries in NVivo to explore similarities and differences between groups of
interviewees (Bazeley & Jackson, 2014). For example, a ‘matrix query’ explored how
interviewees in the different trial arms experienced pharmacological treatments. Overall,
these queries suggested that experiencing and appraising treatments were similar across
566 J. Matthew Harvey et al.
interviewees with different characteristics and from the different trial arms. Therefore,
these queries are reported no further.
Study rigour
To enhance the quality and rigour of this study, we followed Lincoln & Guba’s
guidelines (1985). Trustworthiness was enhanced through keeping a clear audit trail
and having regular discussions of emerging themes and findings within the research
team. Maximum variation sampling helps to increase confidence that we have
captured major themes of importance to a diverse sample of people seeking help for
recurring IBS symptoms. Writing memos and field notes facilitated reflexivity and
enhanced transparency and confirmability. The overarching theme (‘being trapped
within a vicious cycle’) was reminiscent of CBT concepts, prompting a reflexive
exploration of whether CBT concepts had been imposed by the researchers. The lead
analyst ( JMH) was a mature male postgraduate health psychology student, with no
formal CBT training. Other researchers were trained and experienced health
psychologists with and without CBT and clinical experience and an academic GP
with expertise in IBS. Before settling on the final themes, we deliberately reviewed
the data to check for inappropriate imposition of CBT concepts.
Findings
Interviewees described an everyday life compromised by an illness that, while not life-
threatening or terminal, often had debilitating consequences for professional, personal,
family, and social domains alike.
IBS can be like – a complete disaster in your life. . . . people don’t associate with it –with – a
condition that is – like really debilitating and I think – its just like very destructive in your life.
(Elijah)
Accounts of treatment seeking for IBS were characterized by a sense of being trapped
within a ‘vicious cycle’ of alternating hope (for new treatments) and despair (on finding
them ineffective). Some interviewees, such as Lucas, discussed how this vicious cycle
impacted them emotionally.
Iwas anxious about being unwell and that causedme anxiety andmade unwell, which caused
me anxiety, so there was a bit of a vicious circle going on and any amounts of – of – of – telling
me – or telling myself – that this is er something that will go away and it wasn’t serious or
whatever, um [didn’t] break that cycle. (Lucas)
While a few interviewees escaped this cycle through increased acceptance of IBS
and improved self-management, others described a constant battle to control
symptoms and a seemingly unending quest for a cure. Typically, participants had
tried multiple interventions before enrolling in the trial and appraised pharmaceutical,
dietary, and alternative treatments in different ways. Figure 1 depicts the interplay
between the themes and subthemes, described below with selected illustrative
quotes. In the text below and Figure 1, main themes are depicted in bold, subthemes
in italics.
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Desperation for a cure and hope for positive effects
On seeking treatment for IBS, participants described desperation for a cure that
manifested in a willingness to try anything, if there was even the slightest chance, it
could offer some relief from symptoms. While they focused mainly on ‘quick fixes’
offered by medicines, non-pharmaceutical alternatives were considered. To identify
potential treatments, participants drew on recommendations and advice from
diverse sources including health care professionals, friends and family, fellow patients,
and the Internet.
Well most of the treatments I’ve tried have either been through friends of friends of friends or
have been recommended because someone in a chat room has recommended them and – so
when you’re desperate, you will try – oh I’ll give that a go. (Sophia)
Interviewees then had tomanage their hope for positive effects from a new treatment.
Some resisted the temptation to hope for a cure (particularly when they had extensive
histories of treatment seeking), despite hearing success stories from other patients.
Others found that success stories and recommendations encouraged them to hope for a
cure:
I had expectations that it would wave a magic wand overnight (Grace)
Appraising the effects of diverse treatments
Having engaged with a treatment, interviewees described appraising it for its helpfulness
in relieving symptoms and offering physiological and psychological benefits. When
Desperation 
for a cure
Hope for positive 
effects
Appraising the effects of 
diverse treatments
Disappointment 
at lack of cure
Feeling exploited
Low confidence 










Figure 1. Thematic map depicting participants’ experiences of seeking and appraising treatments in IBS.
Note: Bold text represents main themes; Italic text indicates subthemes.
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treatments were appraised as helpful, participants regained a sense of control in their
quality of life and could begin breaking the vicious cycle. Finding a treatmentmodality that
relieved symptoms such as bloating in the short-term allowed interviewees to enjoy a
social life with friends and families and take less time off work. More commonly,
participants were disappointed with treatment effects and continued seeking a more
effective treatment.
Medications
Medications were the most frequently appraised interventions. Some participants
described how medications offered temporary symptom relief (e.g., from bloating
and stomach cramps) that meant they regained some control and were better able to
socialize and perform daily activities without worrying that their symptoms would
interrupt or embarrass them. Indeed, such worries could be all-encompassing and
disabling in themselves so the relief from worry was valued as well as the relief from
symptoms.
It’s made my life easier in that respect, that I don’t get caught out in situations where I would
have been caught out before. So it’s a relief that you can get on andnotworry about it. (Jessica)
When over-the-counter medications and prescribed medications were found to be
unhelpful in that symptom relief was not forthcoming, interviewees often persisted in
trying different remedies and typically remained open to their potential benefits for
others:
Okay, well – none of them really helped so I didn’t – I didn’t really like any of them. Yes – they
just – they did not helpmy –my troublesome symptoms, the bloating and the trappedwind at
night, so you know, I tried all of them for,whatever, amonth or some of them I tried for longer
and tried – on – you know – separate occasions. (Alice)
Over half of all participants expressed a general dislike of takingmedications for their
IBS, citing the following reasons: tablets difficult to swallow, inconvenience of having to
take the medication at very specific times, concerns about falling foul of legal restrictions
when travelling, childhood upbringing was generally antimedications, concerns over
immediate and longer-term side-effects, feeling that medications treated (or masked) the
symptoms without addressing underlying causes, and not understanding what they were
putting into their bodies.
I don’t like taking drugs because I always wonder what – what side-effects are there that
perhaps aren’t apparent now, but you then find out, say, 10 or 20 years down the line for
example. (Liam)
A general dislike of medications and/or finding them ineffective led many participants
(42%) to seek other ways of managing IBS (although they did not necessarily stop taking
disliked medications if they provided some relief). Participants preferred alternatives to
medication which treat IBS more holistically and avoid the use of chemicals, for example
by managing their diet or working with a therapist.
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I just didn’t like the fact that I would have to take medication for – for something that could
possibly be controlled in other ways, through perhaps – work with a therapist or
hypnotherapy or something like that. (Olivia)
Dietary advice
Unlike medications, dietary changes were seen to have a social context which shaped
participants’ appraisals of such interventions. Participants described experiencing an
altered relationship with food which could be empowering (when it became a way of
controlling symptoms) but also demanding. Trying to identify triggers involved something
of a trial and error approach, and when trigger foods were identified, this was
experienced as a double-edged sword. On the one hand, it could enhance participants’
sense of control in cases when their symptoms improved. On the other hand, it could be
burdensome and created additional anxieties, in that it required considerable forward
planning, necessitated detailed attention to ingredients when food shopping or eating
out, and impacted on participants’ work, social, and family lives.
My work involves a lot of travelling and not really any regular hours. So to get into any sort of
routinewith, say, food, is very tricky and doesn’t leavemuchoption for eating anything on the
go, so everything has to be cooked in advance, prepared and brought with me. (Noah)
I dislike that I have to eat differently to my family; I dislike that it’s not readily available to buy
things while I’m out with others. (Emily)
Managing symptoms through diet decreased participants’ enjoyment of food.
Interviewees described finding food boring as they could only eat the same things, they
disliked feeling unable to eat spontaneously, and they missed previously enjoyed foods
and previously pleasurable aspects of food preparation.
Also I decided that food is obviously something that’s really nice to enjoy so it’s just really sad
when you –when you can’t eat like half the foods that you used to eat before. So I found that
really – like demoralising. (Elijah)
Furthermore, some participants reported having managed the demands of complex
dietary changes but without success.
Diet was just very imposing and no positive outcome. So you don’t mind, you know, doing
something that’s restricting your life if you’re going to get something out of it. I got zero out of
it so that was frustrating. (Poppy)
CAM and other treatments
Twenty-four interviewees (N = 46%) described having sought other options including
CAM, colonic pack for manual bowel evacuation, and exercise. While some of these
approaches were valued for attempting to address root causes of IBS, and not being
pharmacological, ultimately, they were appraised according to whether they elicited
meaningful benefits. As for dietary advice and medications, alternatives that were found
ineffective were simply seen as another failed attempt that led to frustration and a
renewed search for other remedies.
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I’ve tried all sorts, I mean, you know, I’ve had tablets, I’ve been to the pain clinic and tried
mindfulness meditation; I’ve paid for hypnotherapy, I’ve paid for acupuncture, paid for
Chinesemedicine, I’ve been to homoeopaths, I’ve paid for that. I’ve tried all sorts and nothing
– nothing works. I’ve had CBT in the past and it didn’t work then. I’ve tried all sorts. (James)
When alternatives such as regular exercise were appraised more positively as helping
with one’s symptoms, participants also reported experiencing challenges to adherence
including lack of time and motivation, feeling lethargic, working long hours, and lacking
enthusiasm for physical activities that were not inherently enjoyable.
I just found it too – too energetic becausemy energy levels can be pretty low sometimes and I
just felt – it wore me out too much, that I didn’t really get pleasure in it, I suppose that’s the
word, I didn’t find it was pleasurable. (Amelia)
Disappointment at lack of cure
Irrespective of their hopes, expectations, or type of intervention, interviewees described
being disappointed when treatments provided neither a cure nor long-term symptom
relief. Interviewees’ desperation to find a cure was fuelled by continuing to experience
symptom flare-ups with little or no ability to manage them, thus maintaining the vicious
cycle of treatment seeking. For example, Isla described being obsessed with keeping
herself regular because of the pain she experienced and seeking different medications for
pain relief.
I was using a lot of over-the-counter laxatives and some of them very strong, and I was just
obsessedwith taking them, just to try and keepmyself regular because I was in somuch pain.
So I would try these ones –which didwork but – theywouldwork but theywould not relieve
the pain. So then I tried taking the other ones that were more [associated] with relieving the
pain and then these actually never worked; I was always in pain. (Isla)
There were additional consequences of having tried ineffective treatments that both
contributed to and were fuelled by disappointment in treatments. Feelings of being
exploited emerged when participants found treatments to be expensive and then
ineffective, and were perpetuated by the constant email bombardment from companies
offering products that promised to provide relief from IBS symptoms.
it’s costing all the time, you know, you’re laying out a lot of moneywhich youmight not mind
if something’s really gone well. But to keep laying out money and, in the end, you’re no
different. (Phoebe)
A lack of confidence in health care professionals sometimes emerged when
participants felt they were being treated as a ‘case of IBS’ rather than a unique individual
person with IBS, when they felt they were not being treated respectfully, when they felt
IBS was dismissed as not serious or ‘all in the mind’, and when they perceived that
clinicians had taken a trial and error approach (to prescribing medications in particular).
This could also decrease participants’ hope for an effective treatment.
you suddenly realise – you are an individual and a lot of doctorswant to put you in one box and
treat you for one specific thing – they don’t look at you as an individual, they look at you as –oh
– you take that medication, blah, blah, blah, follow this routine and you might be cured.
(Amelia)
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I felt a bit hopeless, to be honest [inaudible word]. (I: Yes) I tried quite a few things and I
thought - if the doctor can’t get it right – what hope have I got. (Daisy)
Overall, confidence in a health care professional’s ability to help cure or find
symptom relief appeared to wane when participants’ hopes for success were repeatedly
met with disappointment and at times despair. It is however important to note that not
all participants described losing confidence in health care professionals, and more
positive appraisals of clinicians tended to emerge after effective treatments, helpful
referrals, and respectful discussions that included providing a rationale for any
prescriptions.
and the doctor prescribed that and she was a brilliant doctor and I think, as well, when the
doctor has some confidence, you actually kind of believe in the drug a bit more. She had her
reasons, she explained to me why she was prescribing it, so then I understood the point of it,
not just chucking another prescription at me and telling me to go away. (Sophia)
On experiencing repeated failed interventions, participants began thinking nega-
tively about themselves and the impact IBS had on their quality of life. IBS was seen as a
source of personal embarrassment because of the perceived stigma around it, and because
of uncontrollable bodily reactions. Treatments that offered some relief could also trigger
negative thoughts, for example about the need to rely on medication to help relieve
symptoms and the connotations of using antidepressant medications.
Imean, it’s basically –what’s it called a . . . tricyclic antidepressant. Now, I’mnot depressed by
any stretch of the imagination, I was just a bit – other than the fact that when your IBS [flares
up], yes, you get downbecause – constant trips to the bathroom and obviously theway how it
makes you feel physically. But other than that – if I didn’t havemy IBS, I’d be a perfectly happy
person. (Liam)
Developing acceptance and coping strategies
Some participants had found coping strategies that enabled them to begin to break out of
the vicious cycle of treatment seeking. This occurred when participants, such as Jessica,
felt they had gained a degree of control over their lives, and/or came tounderstand IBS as
a long-term health condition without a permanent ‘cure’.
just coming to terms with the fact that it’s a condition that’s with people forever and er you
just have to try and control it as best you can and there will always be er flare-ups and um days
that are not so good and you just have to – you just have to accept that. (Jessica)
When participants accepted that they had a long-term condition for which there
appeared to be no cure, they seemed better able to resist the temptation to continue
seeking out new treatments in the hope of a magic cure. Instead of seeking an instant
cure, participants took other steps to manage or cope with their symptoms. These
included identifying and avoiding food triggers, stopping or adjusting dosages of
medications, maintaining a routine to reduce feelings of stress, and increasing
exercise.
I’ve it had a long time anyway, it’s not curable; you will try anything but actually the bottom
line is – it’s only one or two small things that really do work – and it’s better just to stick with
them. I see new things come up all the time and I think about them, but, you know, I think –
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well actually – I’mnot going to rock the boat and take something newbecause somebody said,
oh that’s really good – and they make things worse. (Genevieve)
For some interviewees, becoming more aware of their bodies and how their
symptomsmanifest was enough for them to find temporary escape from the vicious cycle
that had engulfed their lives. For Poppy, learning more about herself through the
‘lightning process’ (designed to train people to understand mind–body interactions) was
an empowering process that helped her to cope with her IBS.
I’mnow able to seemy triggers. I amnowable – to controlmyself andmy emotions a lotmore,
take the stress out ofmy life. I’ve now got a huge amount of awareness aboutmyself and how I
react to situations. . . . So – it’s – empowering me as a person, it’s saying use the tools and you
can help yourself – which is really empowering. (Poppy)
Finally, the decision by interviewees to enrol into the trial fits in with their desire and
desperation to find symptom relief on the one hand; and on the other, for those who have
managed to regain some control in their lives, the ability to help develop further tools and
a stronger capacity to self-manage, as both Isla and Amelia explain.
I agreed to do it because, as I said, I was looking for perhaps another tool; I find this is another
tool to help me through what I was experiencing (Amelia)
probably over a year of seeing different doctors and consultants and not finding any solution
to my – to my problem, so it was basically as like a last remedy thing . . . I was not very
optimistic about it (Isla)
Discussion
In this study, we explored how individuals with refractory IBS seek and go about
appraising different treatment modalities. The findings suggest that people primarily
appraise treatment in terms of its perceived impact on reducing symptomseverity but also
in terms of how well it fits within and improves (or not) their personal, social, and
professional lives. However, this must be understood within the broader context of
treatment-seeking behaviours, wherein interviewees described being trapped within a
vicious cycle of hope and despair for a range of different treatment modalities seen as
potential cures.
A desperation and willingness drove interviewees to try any treatment modality
available if it offered potential relief. After a period of time, interviewees appraised the
treatment modality for its effects on symptoms and quality of life while also taking into
account, but rarely prioritizing, other dimensions including convenience of the regimen
itself,whether it sought to address theperceived root causes of IBS, perceived side-effects,
and cost. The Common Sense Model posits a bi-directional relationship between beliefs
about a treatment and appraisals, whether positive (improvement in symptoms) or
negative (side-effects or symptoms persist; Diefenbach & Leventhal, 1996). Therefore, if
the treatment modality proves beneficial, it is predicted that individuals are more likely to
continue engaging with it, and in turn strengthen their beliefs about the treatment
modality as useful in relieving symptoms. In our interviews, people who found the
treatment modality offered some symptom relief, even if it was only in the short-term,
were prepared to continue with it, and in some cases, this was described as ‘life-saving’.
Often, but not always, this was true evenwhen people found a treatment to be difficult to
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adhere to or to have unpleasant or unwanted side-effects. For example, while diet was
seen as a potentially helpful intervention, interviewees did not find it necessarily easy to
adhere to. As Casiday, Hungin, Cornford, de Wit, and Blell (2009) note, managing strict
dietary regimens was time-consuming and frustrating. For Horne (2006), this represents a
‘common sense’ approach to a necessity-concerns dilemma, whereby a highly valued
outcome outweighs problematic aspects of treatment and perceived self-efficacy to
maintain a treatment modality becomes important.
For those trapped within the vicious cycle, disappointment at not being able to
find a way to reduce symptoms and improve quality of life contributed to negative
self-perceptions, feelings of being exploited by marketers, and reduced confidence in
health care professionals. Individuals wanted to have faith in health care
professionals such as GPs and consultants who were often perceived as holding a
lifeline to curing illnesses; when they were unable to provide the answers,
interviewees felt helpless and frustrated. Disappointing experiences with health care
professionals also contributed to negative self-perceptions, when people felt their
symptoms were not being taken seriously or they were not treated as an individual.
Of concern is that the development of negative self-perceptions may further
diminish people’s ability to cope with flare-ups, by reducing self-efficacy and
expectations of response efficacy over time.
Similar reactions have been noted in chronic pain conditions. A meta-synthesis found
that patients with chronic low back pain cycled through hope and despair, were left
frustrated and disappointed when they felt disbelieved by health care professionals and
others, and over time developed more negative perceptions of self and the future (Froud
et al., 2014). Some of these challenges faced by people with chronic painmay result from
not easily fittingwithin a traditional biomedicalmodel inwhich diagnosis leads to curative
treatment (Toye et al., 2013). Indeed, patients often expect a prescription aimed to
alleviate symptoms or cure disease and health care professionals are aware of those
expectations (Cole, 2014; Teixeira Rodrigues, Roques, Figueiras, & Herdeiro, 2013).
Individuals with IBS in the current study felt a similar alienation from the biomedical
model, in that a cure has not followed on from diagnosis and various treatmentmodalities.
Within our interviews, the primary route out of the cure-seeking vicious cycle was
through an acceptance that there is no cure for IBS. For interviewees in the current study,
developing acceptance and coping strategies seemed to increase self-efficacy to manage
periods of flare-ups and provide a protective barrier against despair when a treatment
ceased to reduce symptoms. Similarly, Jakobson Ung et al. (2013)’s interviewees – who
had lived with IBS for a long time (on average 24 years) –were able to see themselves as
‘healed but not cured’ and were able to gain a sense of control in their daily lives.
Acceptance and mastery have also been shown to be important in facilitating coping and
reducing unhelpful cure-seeking in other long-term conditions (see Froud et al., 2014;
Garcia-Rueda, Carvajal Valcarcel, Saracibar-Razquin, & Arantzamendi Solabarrieta, 2016;
Toye et al., 2013). For example, low back pain patients who accepted their condition
might not be curable and changed their outlook accordingly, were better able to cope
with their back pain (Froud et al., 2014).
This study has certain methodological strengths and weaknesses. Strengths include
the use of maximum variation sampling to ensure a broad range of people were
interviewed; the requirement for all interviewees tomeet the Rome III criteria (Drossman,
2006) for IBS; and the use of established techniques to enhance analytic rigour. Our
reflexive exploration of possible imposition of CBT concepts confirmed that the ‘vicious
cycle’ concept had indeed emerged from participants’ accounts. However, it is important
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to bear in mind that interviewees all came from the ACTIB trial (Everitt et al., 2015), and
so all had a history of unsuccessful treatments from primary and/or secondary care. This
means that our participants are very likely to have hadmore unsuccessful or disappointing
experiences of IBS treatments in the past compared to a community-based sample of
people with IBS. At the time of interview, our participants had been in the trial for
3 months: This might have shaped their reflections on treatment seeking. Further, while
this paper did not explore interviewees’ experiences of CBT, their participation in a CBT
trial itself indicates an openness to CBT (and potentially other non-medication-based
interventions) and ongoing treatment seeking.
The findings suggest some clinical implications. Clinicians could encourage
patients to reconceptualize IBS as a condition which they can help to manage
themselves with the right tools. This change in patients’ perceptions of their IBS has
not been a central focus of clinical guidelines. Our findings suggest strengthening
the message that IBS is a relapsing remitting condition, which can persist but can
benefit from active self-management could have potential benefit in breaking the
‘vicious cycle’ of desperately seeking treatment and repeated disappointment.
Promisingly, Robinson et al. (2006) found educating IBS patients with a self-help
guidebook significantly reduced perceived symptom severity and reduced primary
care consultations by 60% compared to controls.
While symptom reduction appears to be highly valued by many, other outcomes such
as regaining a sense of control and rediscovering pleasure in foodmay also be important to
individuals. Initiating dialogue about treatment goals may help to foster better patient–
practitioner interactions in IBS consultations. Such discussions may also enable tailoring
of proposed management strategies to individuals with IBS, focussing on what is
important to them, for example being able to live a valued life despite symptoms.Dialogue
about treatment-related values could also help patients to feel supported in treatment
seeking and encourage treatment choices that are based on amore informed appreciation
of the various costs and benefits of specificmedications such as antidepressants as well as
non-pharmacological interventions.
In conclusion, this qualitative study has illustrated how individuals with IBS seek and
appraise treatments in the context of their personal, social, and professional lives, while
constantly striving for symptom relief. Treatments are experienced on an emotional
rollercoaster of hope through to despair, which for some can be time-consuming and
economically costly. Supportive discussions about illness perceptions and treatment
beliefs during clinical encounters with health care professionals could improve patients’
experiences.
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